Ubiquitylation-independent activation of Notch signalling by Delta

  1. Nicole Berndt
  2. Ekaterina Seib
  3. Soya Kim
  4. Tobias Troost
  5. Marvin Lyga
  6. Jessica Langenbach
  7. Sebastian Haensch
  8. Konstantina Kalodimou
  9. Christos Delidakis
  10. Thomas Klein  Is a corresponding author
  1. Heinrich-Heine-Universität Düsseldorf, Germany
  2. Foundation for Research and Technology - Hellas, Greece

Abstract

Ubiquitylation (ubi) through the E3-ligases Mindbomb1 (Mib1) and Neuralized (Neur) is required for activation of the DSL ligands Delta (Dl) and Serrate (Ser) to activate Notch signalling. These ligases transfer ubiquitin to lysines of the ligands' intracellular domains (ICDs), which sends them into an Epsin-dependent endocytic pathway. Here, we have tested the requirement of ubi of Dl for signalling. We found that Dl requires ubi for its full function, but can also signal in two ubi-independent modes, one dependent and one independent of Neur. We identified two neural lateral specification processes where Dl signals in an ubi-independent manner. Neur, which is needed for these processes, was shown to be able to activate Dl in an ubi-independent manner. Our analysis suggests that one important role of DSL protein ubi by Mib1 is their release from cis-inhibitory interactions with Notch, enabling them to trans-activate Notch on adjacent cells.

Article and author information

Author details

  1. Nicole Berndt

    Institute of Genetics, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany
    Competing interests
    The authors declare that no competing interests exist.
  2. Ekaterina Seib

    Institute of Genetics, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany
    Competing interests
    The authors declare that no competing interests exist.
  3. Soya Kim

    Institute of Genetics, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany
    Competing interests
    The authors declare that no competing interests exist.
  4. Tobias Troost

    Institute of Genetics, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany
    Competing interests
    The authors declare that no competing interests exist.
  5. Marvin Lyga

    Institute of Genetics, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Jessica Langenbach

    Institute of Genetics, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. Sebastian Haensch

    Center for Advanced Imaging (CAi), Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany
    Competing interests
    The authors declare that no competing interests exist.
  8. Konstantina Kalodimou

    Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology - Hellas, Heraklion, Greece
    Competing interests
    The authors declare that no competing interests exist.
  9. Christos Delidakis

    Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology - Hellas, Heraklion, Greece
    Competing interests
    The authors declare that no competing interests exist.
  10. Thomas Klein

    Institute of Genetics, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany
    For correspondence
    thomas.klein@hhu.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2719-9617

Funding

Deutsche Forschungsgemeinschaft (KL 1028/3-1)

  • Thomas Klein

Deutsche Forschungsgemeinschaft (SFB 1208 Teilprojekt B01)

  • Thomas Klein

European Cooperation in Science and Technology (BM1307)

  • Christos Delidakis

General Secretariat for Research and Technology (grant No 4436)

  • Christos Delidakis

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2017, Berndt et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,081
    views
  • 432
    downloads
  • 19
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Nicole Berndt
  2. Ekaterina Seib
  3. Soya Kim
  4. Tobias Troost
  5. Marvin Lyga
  6. Jessica Langenbach
  7. Sebastian Haensch
  8. Konstantina Kalodimou
  9. Christos Delidakis
  10. Thomas Klein
(2017)
Ubiquitylation-independent activation of Notch signalling by Delta
eLife 6:e27346.
https://doi.org/10.7554/eLife.27346

Share this article

https://doi.org/10.7554/eLife.27346

Further reading

    1. Cell Biology
    2. Immunology and Inflammation
    Alejandro Rosell, Agata Adelajda Krygowska ... Esther Castellano Sanchez
    Research Article

    Macrophages are crucial in the body’s inflammatory response, with tightly regulated functions for optimal immune system performance. Our study reveals that the RAS–p110α signalling pathway, known for its involvement in various biological processes and tumourigenesis, regulates two vital aspects of the inflammatory response in macrophages: the initial monocyte movement and later-stage lysosomal function. Disrupting this pathway, either in a mouse model or through drug intervention, hampers the inflammatory response, leading to delayed resolution and the development of more severe acute inflammatory reactions in live models. This discovery uncovers a previously unknown role of the p110α isoform in immune regulation within macrophages, offering insight into the complex mechanisms governing their function during inflammation and opening new avenues for modulating inflammatory responses.

    1. Cell Biology
    2. Genetics and Genomics
    Keva Li, Nicholas Tolman ... UK Biobank Eye and Vision Consortium
    Research Article

    A glaucoma polygenic risk score (PRS) can effectively identify disease risk, but some individuals with high PRS do not develop glaucoma. Factors contributing to this resilience remain unclear. Using 4,658 glaucoma cases and 113,040 controls in a cross-sectional study of the UK Biobank, we investigated whether plasma metabolites enhanced glaucoma prediction and if a metabolomic signature of resilience in high-genetic-risk individuals existed. Logistic regression models incorporating 168 NMR-based metabolites into PRS-based glaucoma assessments were developed, with multiple comparison corrections applied. While metabolites weakly predicted glaucoma (Area Under the Curve = 0.579), they offered marginal prediction improvement in PRS-only-based models (p=0.004). We identified a metabolomic signature associated with resilience in the top glaucoma PRS decile, with elevated glycolysis-related metabolites—lactate (p=8.8E-12), pyruvate (p=1.9E-10), and citrate (p=0.02)—linked to reduced glaucoma prevalence. These metabolites combined significantly modified the PRS-glaucoma relationship (Pinteraction = 0.011). Higher total resilience metabolite levels within the highest PRS quartile corresponded to lower glaucoma prevalence (Odds Ratiohighest vs. lowest total resilience metabolite quartile=0.71, 95% Confidence Interval = 0.64–0.80). As pyruvate is a foundational metabolite linking glycolysis to tricarboxylic acid cycle metabolism and ATP generation, we pursued experimental validation for this putative resilience biomarker in a human-relevant Mus musculus glaucoma model. Dietary pyruvate mitigated elevated intraocular pressure (p=0.002) and optic nerve damage (p<0.0003) in Lmx1bV265D mice. These findings highlight the protective role of pyruvate-related metabolism against glaucoma and suggest potential avenues for therapeutic intervention.